| 160 | 2 | 43 |
| 下载次数 | 被引频次 | 阅读次数 |
目的观察小檗碱对2型糖尿病大鼠骨骼肌病理结构改变及CDK9和cyclin T1蛋白表达的影响。方法腹腔注射链脲菌素(35 mg·kg-1)加高糖高脂饲料喂养16 wk建立2型糖尿病大鼠模型,随后16 wk每天分别拌食给予低中高剂量小檗碱(75、150、300 mg·kg-1)、非诺贝特(100 mg·kg-1)和罗格列酮(4 mg·kg-1),用HE染色检查骨骼肌结构病变和免疫组化检测CDK9和cyclin T1的表达。结果骨骼肌纤维在各组大鼠中仍正常分布,中高剂量小檗碱部分地改善糖尿病肌纤维的萎缩;中高剂量小檗碱和罗格列酮都能明显恢复糖尿病大鼠骨骼肌中表达降低的CDK9和cyclin T1至正常水平(P<0.01)。结论小檗碱调控骨骼肌CDK9和cyclin T1蛋白的表达可能是其改善糖尿病骨骼肌纤维萎缩的机制之一。
Abstract：AIM To investigate the effect of berberine on damaged skeletal muscle and on the cyclin-dependent kinase 9 (CDK9) and cyclin T1 expression in type 2 diabetic rats.METHODS Type 2 diabetes mellitus rats were in- duced by an injection of 35 mg·kg-1 streptozotocin and a high-carbohydrate/high-fat diet for 16 wk.From wk 17 to wk 32,diabetic rats were given low-,middle-,high-dose berberine (75,150,300 mg·kg-1),fenofibrate (100 mg·kg-1) and rosiglitazone (4 mg·kg-1) by oral administration,respectively.The skeletal muscle structure was observed with hematoxylin-eosin (HE) staining and the CDK9 and cyclin T1 expression were detected by immunohistochemistry.RE- SULTS Fibre distribution remained normal in skeletal muscles of all the groups.Middle-,high-dose berberine partly im- proved diabetic fibre atrophy.Middle-,high-dose berberine and rosiglitazone significantly increased the expressions for both of CDK9 and cyclin T1 (P<0.01).CONCLUSION Berberine modulates the CDK9 and cyclin T1 expressions in diabetic skeletal muscle and ameliorates the fibre damage.
[1]UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glu- cose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].Lancet,1998,352(9131):837.
[2]Taskinen MR.Diabetic dyslipidemia[J].Atheroscler Suppl,2002,3 (1):47.
[3]Kang W,Wei J,Abidi P,et al.Berberine is a novel cholesterol-lower- ing drug working through a unique mechanism distinct from statins[J]. Nat Med,2004,10(12):1344.
[4]Dynlacht B.Regulation of transcription by proteins that control the cell cycle[J].Nature,1997,389(6647):149.
[5]Tang LQ,Wei W,Chen LM,et al.Effects of berberine on diabetes in- duced by alloxan and a high-fat/high-cholesterol diet in rats [J].J Ethnopharmacol,2006,108(1):109.
[6]Banz WJ,Davis J,Steinle JJ,et al.(+)-Z-Bisdehydrodoisynolic acid ameliorates obesity and the metabolic syndrome in female ZDF rats[J]. Obes Res,2005,13(11):1915.
[7]Xie W,Xing D,Sun H,et al.The effects of Ananas comosus L.leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high- cholesterol diet[J].Am J Chin Med,2005,33(1):95.
[8]Ye JM,Doyle PJ,Iglesias MA,et al.Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves in- sulin sensitivity in high fat-fed rats:comparison with PPAR-gamma acti- vation[J].Diabetes,2001,50(2):411.
[9]Khan MA,St Peter JV,Xue JL.A prospective,randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone[J].Dia- betes Care,2002,25(4):708.
[10]Huang C,Zhang Y,Gong Z,et al.Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR gamma pathway [J]. Biochem Biophysi Res Commun,2006,348(2):571.
[11]Brusq JM,Ancellin N,Grondin P,et al.Inhibition of lipid synthesis through activation of AMP kinase:an additional mechanism for the hy- polipidemic effects of berberine[J].J Lipid Res,2006,47(6):1281.
基本信息:
DOI：10.19577/j.cnki.issn10074406.2008.04.001
中图分类号:R587.1
引用信息:
[1]周吉银,周世文.小檗碱对链脲菌素和高糖高脂饲料诱导糖尿病大鼠骨骼肌CDK9和cyclin T1表达的影响(英文)[J].中国临床药学杂志,2008(04):195-200.DOI:10.19577/j.cnki.issn10074406.2008.04.001.
2008-07-25
2008-07-25